Arun Balakumaran
SVP, Head of Clinical Development
Allogene Therapeutics
Jan ter Meulen
CSO
Obsidian Therapeutics
Guanglin Yu
Senior Expert Science & Technology
Novartis
Paul Rennert
Acting CEO, President, CSO
Aleta Biotherapeutics
Laura Johnson
Chief Scientific Officer
Verismo Therapeutics
Francesco Marincola
Global Head of R&D
Kite Pharma
Christopher Pastorello
Director, Head of GMP Operations
Century
Peter Bross
Chief, Oncology Branch, Office of Tissues and Advanced Therapeutics, Center for Biologics Evaluation and Research
FDA
Michael Leek
Executive Chairman
TC Biopharm
Stefanie Bailey
Research Fellow
Massachusetts General Hospital and Harvard Medical School